GL1X · GenesisL1 explorer

Research workbench

Targeted polypharmacology: crystal structure of the C-src kinase domain in complex with S1, a multitargeted kinase inhibitor

Analyse Targeted polypharmacology: crystal structure of the C-src kinase domain in… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3EN7
Type
protein
Length
484 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proto-oncogene tyrosine-protein kinase src
EC
2.7.10.2
UniProt
P00523
Ligands
ABJ
Pockets
4 · best druggability 0.69

Structure

x-ray diffraction · 2 distinct chains · 43% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein24744% helix, 15% strandP00523
BProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein23742% helix, 17% strandP00523

Ligands and binding sites

  • ABJ · 3-[4-amino-1-(1-methylethyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]phenol · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16900.690.7789ABJ
24070.620.7745empty
32030.510.7632empty
4550.270.7412empty

Interfaces

1 interface between chains.

  • A–B · 371 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 3EN7 · Targeted polypharmacology: crystal structure of the c-Src kinase domain in complex with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.